In Philadelphia chromosome (Ph1)-positive human leukemia, the c-Abl tyrosine kinase is activated by fusion to sequences encoded by the breakpoint cluster region (bcr) gene. Two major types of Bcr-Abl fusion proteins have been found in human leukemia. Fusion of the N-terminal 426 amino acids of Bcr generates p190
Bcr-Abl which is mostly found in acute lymphocytic leukemia (ALL), whereas fusion of the N-terminal 902 or 927 amino acids of Bcr generates p210
Bcr-Abl mostly found with chronic myelogenous leukemia (CML) . Previous studies have demonstrated that both the Bcr and the Abl functional domains contribute to the oncogenic activity of Bcr-Abl proteins. Present in both p190 and p210 is the N-terminal coiled-coil of Bcr (aa 1 ± 63), which is shown here to be functionally replaceable with the leucine zipper of the yeast transcription factor GCN4. The ZIP-Bcr-Abl protein transforms Rat-1/myc cells, is autophosphorylated on tyrosine and localized predominantly to actin ®laments. Thus, formation of homo-oligomers through either Bcr or GCN4 coiled-coil can activate the tyrosine kinase and F-actin binding functions of Abl. We also found that a Bcr-Abl fusion containing only Bcr amino acids (1 ± 191) can eciently transform Rat-1/myc cells. Fusion of additional Bcr sequences (aa 192 ± 923) did not aect the transformation of Rat-1/myc cells but progressively reduced the disruptive eect on the actin cytoskeleton. In particular, the Dbl homology domain present in p210 Bcr-Abl but not in p190 Bcr-Abl 
Introduction
The Breakpoint cluster region (Bcr) gene was ®rst identi®ed through the study of the Philadelphia (Ph1) chromosome which is the cytogenetic hallmark of chronic myelogenous leukemia (CML). About 5% of acute lymphocytic leukemia (ALL) also show the formation of the Ph1-chromosome (Daley and BenNeriah, 1991) . In the Ph1-chromosome, the bcr gene on chromosome 22 is linked to the c-abl proto-oncogene on chromosome 9 leading to the generation of novel BcrAbl fusion proteins. Bcr and c-Abl are each composed of several functional domains. It is the combination of these functional domains in Bcr-Abl that leads to the formation of a transforming protein. The oncogenic activity of Bcr-Abl can be demonstrated in a number of in vitro assays, including the morphological transformation of rodent ®broblasts (Lugo and Witte, 1989) , the abrogration of interleukin-3 (IL-3)dependence (Daley and Baltimore, 1988) , and the induction of long-term survival of bone marrow cells in culture (McLaughlin et al., 1987) . In every assay the tyrosine kinase activity provided by the Abl moiety is essential to transformation. Activation of the Abl tyrosine kinase, we have shown, is mostly due to an N-terminal coiled-coil domain of Bcr (McWhirter and Wang, 1991; . We have proposed that homo-oligomerization is the key mechanism for the activation of Bcr-Abl tyrosine kinase . Previous studies have identi®ed several other functional domains in BcrAbl to be important in transformation. However, the contribution of these domains is dependent on the transforming assays. For example, tyrosine 177 of Bcr, a binding site for SH2 domains such as the one in the adaptor GRB2, is required for the transformation of Rat-1/myc cells (Pendergast et al., 1993; Puil et al., 1994) , but dispensable for transformation of bone marrow cells (Goga et al., 1995) . The SH2 domain of Abl is required for the transformation of Rat-1/myc cells and bone marrow cells, but is not required for the abrogation of IL-3 dependence . Taken together, these results suggest that Bcr-Abl can aect a number of cellular processes and these processes may contribute dierentially to the transformed phenotypes.
A mouse model for CML has been constructed by the reconstitution of lethally irradiated mice with bone marrow cells infected by retrovirus carrying the bcr-abl gene (Daley et al., 1990; Daley and Ben-Neriah, 1991) . However, two other groups reconstituted mice with the same method but those mice and a bcr-abl transgenic line developed acute lymphocytic leukemia (Elefanty et al., 1990; Heisterkamp et al., 1990; Kelliher et al., 1990) . Further re®nement of the mouse model appears to be required to develop in vivo assays for the pathogenic eects of Bcr-Abl. Insight into the disease mechanism has come from studies of CML patient samples in long term bone marrow cultures. These studies have uncovered a CML-defect, that is the apparent reduction in the adhesiveness of the CML stem cells to the stromal layer (Dowding et al., 1991; Verfaillie et al., 1992) . Interestingly, the reduced adhesion can be corrected by treatment with interferon-alpha, and this is correlated with the remission of the disease (Dowding et al., 1991; Bhatia et al., 1994 Bhatia et al., 1995 . The reduced adhesiveness may provide the CML stem cells with a growth advantage in the bone marrow microenvironment to allow the expansion of the Ph1-positive cells in the hematopoietic compartments (Dowding et al., 1991; Verfaillie, 1992) .
The adhesive defect may have its basis in the cellular function of the Bcr-Abl protein. We have previously described that Bcr-Abl is predominantly associated with ®lamentous actin Wang, 1991, 1993) . In cultured ®broblastic cells, Bcr-Abl is found decorating the F-actin stress ®bers. In CML cell lines, such as K562, Bcr-Abl is associated with the cortical actin ®laments . We have localized in the C-terminal region of c-Abl an F-actin binding domain . This was later con®rmed by Van Etten et al., (1994) who also identi®ed a G-actin binding function in c-Abl. The F-actin binding function of c-Abl is also activated by the N-terminal coiled-coil of Bcr (McWhirter and Wang, 1991; . The Bcr coiledcoil can form homo-dimers, trimers and tetramers, as demonstrated by cross-linking experiments . The oligomerization of the F-actin binding domain may provide the Bcr-Abl protein with the capability to cross-link F-actin ®laments, and thus leading to the stable association of Bcr-Abl with the cytoskeleton. The F-actin binding function contributes to the transformation of rodent ®broblasts as well as the abrogation of IL-3 dependence . Moreover, our lab has shown that Bcr-Abl renders NIH3T3 cells independent of anchorage for proliferation (Renshaw et al., 1995) . Again, the F-actin binding function is required for Bcr-Abl to induce anchorage-independent growth (Renshaw et al., 1995) .
Several lines of evidence suggest that Bcr may also be functionally linked to the modulation of the cytoskeleton. First, Bcr contains a Dbl-homology domain which encodes a guanine nucleotide exchange factor activity (Cerione and Zheng, 1996) . The Dbl protein can activate Rho (Chuang et al., 1995) . The activated Rho can in turn promote the formation of Factin stress ®bers . This Dblhomology domain of Bcr is present in p210
Bcr-Abl , but not in p190
Bcr-Abl (Daley and Ben-Neriah, 1991) . Second, the C-terminal region of Bcr contains an GTPase-activating protein function for the small GTPase Rac (Ridley et al., 1993) . Activation of Rac stimulates membrane ruing and pinocytosis , thus, the Rac-GAP function of Bcr may play a role in the downregulation of membrane ruing and pinocytosis. Rac is also known to play an important role in the ligand-mediated activation of oxidative burst in neutrophils (Diekmann et al., 1994) . A mouse mutant with homozygous disruption of the bcr gene is viable (Voncken et al., 1995) . Interestingly, neutrophils from bcr 7/7 mice showed an increase in oxidative burst, consistent with Bcr acting as a downregulator of Rac function (Voncken et al., 1995) . The Rac-GAP domain of Bcr is not present in Bcr-Abl fusion proteins.
In this report, we describe observations showing that Bcr sequences can modulate the eect of the activated Bcr-Abl kinase on the actin-cytoskeleton in ®broblastic and hematopoietic cells. In addition, we show that the N-terminal coiled-coil of Bcr can be functionally replaced with the leucine zipper domain of the yeast transcription factor GCN4. These observations support the idea that a Bcr-Abl homo-oligomer is the transforming agent and that the pathogenic mechanism of Bcr-Abl may be related to its ability to modulate the structure and function of the actincytoskeleton.
Results
The coiled-coil of Bcr can be functionally replaced by the leucine zipper of GCN4, a yeast transciption factor.
We have previously proposed that the coiled-coil of Bcr activates the Abl tyrosine kinase by promoting the formation of Bcr-Abl oligomers (McWhirter et al., Figure 1 Structures of the Bcr, c-Abl, Bcr-Abl and ZIP-Bcr-Abl proteins. The Bcr-Abl constructs used in this study are summarized. The Bcr domains are: Region 1, OLIGO: oligomerization domain, which is the coiled-coil in Bcr aa 1 ± 63 . Region 2, Y177: tyrosine 177 which when phosphorylated binds to the GRB-2 SH2 domain (Pendergast et al., 1993; Puil et al., 1994) . Region 3 SH2-B: SH2 binding domain, in Bcr aa 192 ± 413. This region has been shown to bind several SH2 domains in a phosphotyrosine-independent manner (Muller et al., 1992) . DBL: region of homology to the DBL proto-oncogene which encodes a guanine nucleotide exchange factor for the Rho GTPase (Cerione and Zheng, 1996) . RAC-GAP: domain with GTPase-activating activity for the p21 rac GTPase (Ridley et al., 1993) . The c-Abl domains are: V: variable ®rst exon domain. SH3/2: Src-homology domains 3/2. YK: tyrosine kinase domain. 3 NTS nuclear translocation signals (Wen et al., 1996) . DB: DNA-binding domain (Kipreos and Wang, 1992; Miao and Wang, 1996) . AB: actin-binding domain. The junction points in Bcr in ALL and CML are indicated by arrowheads 1993). If true, we should be able to exchange the Bcr coiled-coil with another oligomerization domain and retain activation. We therefore replaced the N-terminal 63 amino acids of Bcr/1-509-Abl with a coiled-coil from a completely unrelated protein: the leucine zipper from the yeast transcription factor GCN4 (O'Shea et al., 1991) . The C-terminal 34 amino acids of GCN4 which contain the leucine zipper domain were ®tted with a consensus eukaryotic translation initiation sequence and then fused in frame with the Bcr-Abl coding region (Figure 1 , ZIP-Bcr/64-509-Abl). For expression in mammalian cells, the ZIP-Bcr-Abl gene was inserted into the retroviral vector pSLXCMV (Scharfmann et al., 1991) .
The ZIP-Bcr-Abl protein was assayed for transforming activity in Rat-1 ®broblasts which overexpress the c-Myc protein . The ZIPBcr-Abl activity was compared to its cognate Bcr-Abl protein (Bcr/1-509-Abl) and to p210
Bcr-Abl (Bcr/1-923-Abl) (Table 1) . When compared to p210
Bcr-Abl , the ZIPBcr-Abl generated between 30 ± 40% as many foci, and between 30 ± 50% as many soft agar colonies (Table 1) . When compared to Bcr/1-509-Abl, the ZIP-Bcr-Abl generated between 40 ± 60% as many foci and between 40 ± 90% as many soft agar colonies ( Table 1) . As previously reported, the Bcr/64-509-Abl protein lacking the Bcr region 1 has no transforming activity . Disruption of the Bcr coiled-coil with an insertion of b-turn sequence also completely abolishes the transforming activity of BcrAbl (Bcr/1-509(b53)-Abl, Table 1 ). Because ZIP-BcrAbl could transform Rat-1/myc cells, the leucine zipper of GCN4 must be able to replace the coiled-coil of Bcr. However, the foci induced by ZIP-Bcr-Abl appeared 2 ± 3 days later and were, on average, smaller than the foci produced by Bcr/1-509-Abl (Figure 2 , compare panels a and b).
To determine if the lower transforming eciency was related to kinase activity, we examined the extent of autophosphorylation of the ZIP-Bcr-Abl protein in transformed Rat-myc cells as well as in NIH3T3 cells not selected for transformation (Figure 3 ). The Bcr-Abl proteins were immunoprecipitated from the cell lysates and then immunoblotted with antibodies for phosphotyrosine (PTyr) and for Abl (Figure 3 ). In transformed Rat-1 cells, a somewhat higher level of ZIP-Bcr-Abl (lane 5) was observed when compared to its cognate Rat-1/myc cells were cotransfected with 3 mg of Bcr-Abl construct in vector pSLXCMV, 1 mg of pRSVHyg, and 18 mg of salmon sperm DNA. Two days later, the cells were split into three parts and selected for hygromycin-resistance, foci formation or soft agar colony formation. Table 1 were photographed after 14 days of growth using a Nikon inverted microscope with phase contrast optics at 406 magni®cation Bcr/1-509-Abl (lane 2). However, the PTyr to protein ratio was similar between the two proteins, indicating that the GCN4 leucine zipper activated Abl tyrosine kinase as eciently as the Bcr coiled-coil. In NIH3T3 cells not selected by transformation, the ZIP-Bcr-Abl protein was expressed at a much lower level than BcrAbl (compare lane 8 to 6), suggesting that the ZIP-BcrAbl protein might be less stable. Again, the PTyr to protein ratio was similar, whereas no PTyr was detected in the Bcr(b53)-Abl protein (lane 7). These results showed that the auto-kinase activity of Abl could be activated equally well by the Bcr coiled-coil or the GCN4 leucine zipper. The lower transforming eciency of ZIP-Bcr-Abl was therefore not related to lower kinase activity.
We have previously shown that Bcr-Abl is predominantly associated with ®lamentous actin in the cytoplasm Wang, 1991, 1993) . The coiled-coil of Bcr is also responsible for enhancing an actin-binding function at the C-terminal end of c-Abl Wang, 1991 1993) . To determine if the leucine zipper also activates the actin-binding function, the localization of ZIP-Bcr-Abl protein in Rat-1/myc cells was examined by double-label immunofluorescence using a monoclonal antibody for Abl and uorescein-conjugated phalloidin. Similar to Bcr-Abl, ZIP-Bcr-Abl was completely cytoplasmic and most of it colocalized with F-actin (Figure 4, b and c) . In cells that were spread out, both Bcr-Abl and ZIP-Bcr-Abl colocalized with actin stress ®bers (left sides of panels b and c). In more rounded cells, both proteins were associated with the dot-like actin structures in the cytoplasm (right sides of panels b and c). When the Rat-1/myc cells were extracted with a buer containing 1% Triton X-100, both proteins were found to be predominantly associated (*65%) with the detergentinsoluble pellet. Under the same extraction conditions, only 14% of c-Abl was found in the detergentinsoluble pellet (McWhirter and Wang, 1991) . These results indicated that the actin-binding function of cAbl was enhanced by oligomerization through either the Bcr coiled-coil or the GCN4 leucine zipper. Thus, the lower transforming eciency of ZIP-Bcr-Abl could not be due to altered subcellular localization. The BcrAbl protein can associate with the endogenous Bcr protein through the coiled-coil tetramerization domain (Campbell et al., 1990; Liu et al., 1993; . It is possible that the recruitment of the cellular Bcr, which is not likely to occur with ZIP-BcrAbl, can contribute to the transforming activity of BcrAbl.
Contribution of the SH2-binding region of Bcr to BcrAbl activation
Previous reports have suggested that the SH2-binding function of Bcr is important for the activation of Abl tyrosine kinase (Pendergast et al., 1991) . The SH2 binding function of Bcr is mapped to region 3, within Bcr amino acids 192-413 as shown in Figure 1 (Pendergast et al., 1991) . These Bcr sequences can bind to the c-Abl SH2 domain, as well as to several other SH2 domains, in a phosphotyrosine-independent manner (Pendergast et al., 1991; Muller et al., 1992) . Previous studies have also shown that the Bcr region 2, containing Bcr Y177, is necessary for the transformation of Rat-myc cells (Pendergast et al., 1991 (Pendergast et al., , 1993 . The role of Bcr aa 192 ± 413 in transformation was not clearly resolved in the previous studies. To clarify this point, a bcr-abl gene was constructed which lacked region 3 (Bcr aa 192 ± 413), but retained regions 1 and 2 (Figure 1 , Bcr/1-191-Abl).
The Bcr/1-191-Abl protein transformed Rat-1/myc cells and did so more eciently than Bcr/1-509-Abl (Table 1) . In contrast, a protein missing Y177 (Bcr/1-175-Abl) had no detectable transforming activity (Table 1 ). The tyrosine kinase activity of Bcr/1-191-Abl was activated in Rat-1/myc cells as shown by immunoblotting with antibodies to PTyr (Figure 3 , lane 4). Although the region 3 of Bcr was not required for transformation, its eect on the tranformed phenotype could be observed. The foci produced by Bcr/1-191-Abl were distinctly dierent in appearance than those produced by the Bcr-Abl proteins containing region 3 (Figure 2 , compare A and B to C). Both the Bcr/1-509-Abl and the ZIP-Bcr-Abl foci consisted of compact mounds of highly-rounded, almost spherical cells (Figure 2 a and b) ; whereas Bcr/1-191 foci consisted of loosely associated, fusiform cells which tended to spread rapidly over a large area of the monolayer (Figure 2, c) . Therefore, Bcr/1-191-Abl transformed cells appear to have decreased intercellular adhesion and/or an increased ability to migrate over the monolayer relative to cells transformed by Bcr-Abl proteins containing the region 3 sequences of Bcr. Figure 4 Immuno¯uorescent staining of Bcr-Abl and ZIP-Bcr-Abl proteins in Rat-1/myc cells. Cell lines isolated from soft agar colonies were grown overnight on glass cover slips. The next day, they were ®xed with 3% paraformaldehyde, permeabilized with 0.1% Triton X-100 and prepared for immuno¯uorescence using monoclonal antibody 8E9 plus rhodamine-conjugated goat antimouse to visualize Bcr-Abl (ANTI-ABL) and¯uorescein-conjugated phalloidin to visualize F-actin (PHALLOIDIN)
Bcr sequences modulate the eect of Bcr-Abl on F-actin
To determine the reason for the dierence in morphology, the localization of Bcr/1-191-Abl and the structure of ®lamentous actin in these cells were examined by indirect immuno¯uorescence (Figure 4) . Two types of F-actin structures were observed with cells transformed by Bcr/1-509-Abl (Panel b), as previously described . With cells that retained the¯at morphology, F-actin stress ®bers are detected (left, PHALLOIDIN) and these ®bers are decorated with Bcr/1-509-Abl (left, ANTI-ABL). With more rounded cells, stress ®bers are less prominent (right, PHALLOIDIN) and the appearance of the F-actin-positive granular dots can be observed as previously described . These F-actin-positive dots also contained Bcr-Abl (right, ANTI-ABL). The ZIP-Bcr-Abl transformed cells exhibited the same two types of F-actin structures (c). In¯at cells, ZIP-Bcr-Abl was found to decorate Factin ®bers; whereas in round cells, ZIP-Bcr-Abl is localized to F-actin containing granules. With the deletion of Bcr aa 191-509, a dierence result was obtained. The Bcr/1-191 transformed cells contained no detectable stress ®bers; only cortical F-actin at the plasma membrane was observed (panel d, PHALLOI-DIN). Bcr/1-191-Abl was localized to the cortical Factin, but it was also detected in the cytoplasm as diuse staining and completely excluded from the nucleus (panel d, ANTI-ABL). In a few cells, Bcr/1-191-Abl was localized in cytoplasmic dots (panel d, ANTI-ABL, note the four cells in the center of the photgraph each with a single bright dot). However, these dots did not contain detectable F-action (panel d, PHALLOIDIN). In fractionation experiments, approximately 65% of Bcr/1-191-Abl was found associated with the detergent-insoluble matrix (data not shown), supporting its association with the cortical cytoskeleton. These observations suggested that region 3 of Bcr, which is present in Bcr/1-509-Abl and ZIP-Bcr-Abl but absent from Bcr/1-191-Abl, might play a role in preventing the complete disruption of the actin stress ®bers by the oligomerized Abl kinase.
The Bcr/1-509-Abl lacks Bcr amino acids that are found in the p210
Bcr-Abl or CML. The translocation breakpoints are such that either 902 or 927 amino acids of Bcr are fused to c-Abl in p210
Bcr-Abl (Daley and BenNeriah, 1991) . As discussed in Introduction, p210
Bcr-Abl contains a guanine nucleotide exchange domain that is homlogous to the Dbl oncogene. Dbl has been shown to activate the small GTP-binding protein Rho which promotes the formation of actin stress ®bers Chuang et al., 1995; Cerione and Zheng, 1996) . The addition of Bcr aa 510 ± 923, including the Dbl-like domain, increased the transforming eciency in Rat-myc cells (Table 1) . When Bcr/1-923-Abl transformed cells were analyzed for Factin structure, F-actin stress ®bers were prominent (Figure 4, a, PHALLOIDIN) . The Bcr/1-923-Abl protein was associated with the actin stress ®bers (panel a ANTI-ABL). Interestingly, the F-actin containing, dotlike cytoplasmic granules found in Bcr/1-509-Abl transformed cells were not detected in cells transformed by Bcr/1-923-Abl. The eects of the dierent Bcr-Abl proteins on the F-actin structure is summarized in Table 2 .
This dierence in F-actin structure was also observed when the shorter and the longer forms of Bcr-Abl proteins were expressed in the IL-3-dependent Ba/F3 cells ( Figure 5 , compare panels a and b). In these round cells, the longer Bcr/1-923-Abl was localized in the cortical F-actin with no detectable dot-like structures ( Figure 5B ). The staining of Bcr-Abl with anti-Abl is much more ecient than the staining of the endogenous c-Abl. When the non-transfected Ba/F3 cells were stained (panel c), a diuse cytoplasmic and nuclear background stain was observed at a much longer exposure. The staining pattern and the colocalization with cortical F-actin or Bcr/1-923-Abl is similar to the previous observation made with K562 cells, a human CML cell line. In K562 cells, P210
Bcr-Abl is found to associate with the cortical F-actin and no dot-like structures were observed . In contrast, the shorter Bcr/1-509-Abl caused a disruption of the cortical F-actin and induced the formation of cytoplasmic F-actin positive dots in these Ba/F3 cells ( Figure 5A ). Taken together, these results suggest that Bcr sequences between aa 510 and 923 can contribute to the stabilization of actin ®laments and this may be due to the Dbl-homolgy domain.
The localization of Bcr/1-509-Abl was found to be altered in Ba/F3 cells undergoing mitosis. In metaphase (large arrow head, upper panel in a, HOECHST) or anaphase cells (small arrow, lower panel in A, HOECHST), Bcr/1-509-Abl localization became much more diuse and the cytoplasmic dots were no longer present (large arrowhead and small arrow, upper and Gag-v-Abl 7 7 7 7 ++ 7 ++++ a The Bcr regions are shown in Figure 1 : Region 1, the coiled-coil oligomerization domain; Region 2, the Y177 GRB2 binding site; Region 3, the SH2 binding domain; Region 4, The Dbl-homology domain. The level of stress ®bers in Rat-1/myc cells was compared to untransformed counterparts by immuno¯uorescence staining of cells with Phalloidin (Figure 4 ). Complete loss of stress ®bers, ++; complete or partial loss of stress ®bers, +; detectable decrease in stress ®bers +/7; normal stress ®bers, 7. The induction of cytoplasmic F-actin granules is shown in Figure 4 . F-actin dots are also found in Ba/F3 cells ( Figure 5 ). Transformation of Rat-1/myc cells is summarized in Table 1 and previously described (McWhirter and Wang, 1991 lower panels in a, ANTI-ABL). In metaphase cells, only cortical F-actin was present with no cytoplasmic dot (large arrowhead, upper panel in a, PHALLOIDIN). In anaphase cells, no F-actin was detected (small arrow lower panel in a, PHALLOIDIN. In telophase cells (small arrowhead upper panel in a), association of Bcr-Abl with the cortical F-actin was again detected with the re-appearance of the cytoplasmic dots ( Figure 5A , small arrowhead). In metaphase cells, with the activation of the M-phase promoting factor (MPF), the c-Abl protein is extensively phosphorylated at seven cdc2-consensus Ser and Thr sites (Kipreos and Wang, 1990) . In fact, Bcr-Abl is also modi®ed at these sites in metaphase cells (Kipreos and Wang, unpublished) . Results shown in Figure 5 suggests that Mphase modi®ed Bcr-Abl protein does not cause the formation of F-actin dots. Thus, the disruptive eect of Bcr/1-509-Abl on F-actin maybe neutralized in metphase cells through phosphorylation on speci®c Ser and/or Thr sites. This MPF-mediated modi®cation may allow Bcr-Abl transformed cells to re-model the F-actin cytoskeleton during mitosis.
Discussion
We have shown that the GCN4 leucine zipper can replace the Bcr coiled-coil in Bcr-Abl. This result supports the hypothesis that oligomerization is key to the oncogenic activation of Abl . Additional evidence for this has come from the discovery of a fusion between c-abl and the TEL gene, in a Ph1-chromosome-negative ALL patient (Papadopoulos et al., 1995; Golub et al., 1996) . Common to the TEL-Abl, Bcr-Abl and ZIP-Bcr-Abl proteins is the formation of homo-oligomers through three dierent oligomerization domains. The TEL-Abl protein, like Bcr-Abl and ZIP-Bcr-Abl, is also associated with Factin (Golub et al., 1996) . Thus, activation of the Abl tyrosine kinase in human leukemia is mediated by the clustering of kinase domains, not unlike the ligandmediated activation of receptor tyrosine kinases. In addition to forming homo-oligomers, Bcr-Abl is also capable of forming hetero-oligomers with the normal p160
Bcr protein (Campbell et al., 1990; Liu et al., 1993) . Because ZIP-Bcr/-Abl is not likely to form a complex with p160 Bcr , this interaction may not be essential for the transformation of Rat-1/myc cells. However, the reduced ability of ZIP-Bcr-Abl to transform Rat-1/myc cells suggests that recruitment of Bcr into the Bcr-Abl complex may enhance transformation. In this regard, p160
Bcr was recently shown to function in transformation by the Fes tyrosine kinase oncogene (Maru et al., 1995) . In Fes-transformed cells, Bcr becomes phosphorylated on tyrosine and forms a complex with GRB2 and SOS. In addition, tyrosine phosphorylation of Bcr leads to the inhibition of the Bcr serine kinase activity . The recruitment of Bcr by Bcr-Abl through the Bcr coiled-coil may therefore contribute to Bcr-Abl mediated transformation.
The Bcr sequence between aa 175 ± 191 is critical for transformation of Rat-1/myc cells (Table 1 ) most likely because this region contains tyrosine 177 which when phosphorylated binds to GRB2 (Pendergast et al., 1993; Puil et al., 1994) . There is strong evidence that Bcr-Abl must form a complex with GRB2 in order to transform ®broblastic cells (Pendergast et al., 993; Puil et al., 1994) . The association of Bcr-Abl with GRB2 is thought to induce the constitutive activation of the mitogenic RasRaf-MAP-kinase signaling pathway. However, Kabarowski et al. were unable to detect activation of the MAPkinase in cells expressing a temperature-sensitive mutant of p210
Bcr-Abl after shifting them to the permissive temperature (Kabarowski et al., 1994) . Because BcrAbl is not localized to the plasma membranes where RasRaf are activated by mitogenic factors, the Bcr-Abl-GRB2 complex may signal through alternative downstream pathways that do not directly involve the MAPkinase cascade. In Ba/F3 cells, Bcr-Abl can abrogate the IL-3 requirement for proliferation and this has been taken as evidence that Bcr-Abl can stimulate the mitogenic pathway. Interestingly, the mitogenic response to IL-3 is not inhibited by a dominant negative Ras mutant in Ba/F3 cells (Koji et al., 1995) . However, the IL-3 mitogenic activity can be blocked by a tyrosine kinase inhibitor (Koji et al., 1995) . The recent ®nding that Bcr-Abl may directly phosphorylate the IL-3 receptor indicates an alternative mechanism of signaling to abrogate IL-3 dependence (Wilson-Rawls et al., 1996) .
In a subclone of NIH3T3 cells (P-3T3 cells), Bcr-Abl abrogates the anchorage-but not the growth factorrequirement for proliferation (Renshaw et al., 1995) . In P-3T3 cells, Bcr-Abl does not induce the TPA-response element (TRE) of the c-jun promoter, as would be expected if it activated the Ras pathway. Instead, BcrAbl allows serum to induce the TRE in the absence of cell-substrate adhesion in these P-3T3 cells. Moreover, this activity of Bcr-Abl was not blocked by dominantnegative mutants of Ras or Raf, suggesting that the TRE activation occurs through a Ras-independent pathway (Renshaw et al., 1995) . The ability of Bcr-Abl to induce anchorage-independent growth in ®broblasts requires that the protein be localized on actin ®laments ) . Taken together, these results suggest that Bcr-Abl may constitutively activate an adhesion-mediated signaling pathway to induce anchorage-independent but not growth factor-independent proliferation. Recently, the c-Abl tyrosine kinase has been shown to be regulated by cell adhesion (Lewis et al., 1996) . When ®broblasts are detached from the extracellular matrix (ECM), c-Abl becomes inactive. Re-attachment to the ECM or the ligation of integrins, which are receptors of the ECM, re-activates c-Abl tyrosine kinase with a rapid kinetics. Because c-Abl tyrosine kinase is regulated by integrins, the activated Bcr-Abl may transduce a constitutive adhesion signal to provide a growth advantage to cells.
Our results suggest that Bcr region 3 and Dblhomology domain may contribute to the stabilization of actin stress ®bers in transformed cells (Figures 4 and  5) . The mechanism by which Bcr region 3 stabilizes Factin is unclear. The only known function of Bcr region 3 is to bind SH2 domains (Muller et al., 1992) . This SH2 binding function may contribute to the formation of some stress ®bers and the F-actincontaining cytoplasmic dots in Bcr/1-509-Abl and ZIP-Bcr-Abl transformed cells. The further stabilization of F-actin stress ®bers in ®broblasts and cortical F-actin in BaF3 cells by the Dbl-homology domain is reasonable. This Dbl-homology domain can conceivably activate Rho which is known to stimulate actin polymerization. Morphology of cells transformed by Bcr/1-191-Abl, which lacks Bcr region 3 and the Dblhomology domain, is very similar to that of Gag-v-Abl (Table 2 ). In fact, Gag-v-Abl transformed cells also contained only cortical F-actin with no detectable stress ®bers . This may represent the eect induced by an activated Abl tyrosine kinase, and the Bcr sequences between amino acids 191 and 923 may counteract that eect by progressively stabilizing the actin-®laments.
Thus far we have not observed a correlation between the eects of Bcr-Abl proteins on actin structure and their transforming potency in ®broblasts. However, the ®broblast transformation assay may not accurately re¯ect the process of leukemogenesis. In Ph1-positive leukemic cells, both p210 and p190 transcripts can be detected. A recent quantitative survey found that 88% of chronic phase CML express both p210
Bcr-Abl and p190
BcrAbl transcripts but the p210 Bcr-Abl transcript represents the overwhelming majority with a mean p190/p210 ratio of 2610 74 (van Rhee et al., 1996; Melo, 1996) . However, in p210
Bcr-Abl -positive ALL, a much more aggressive disease, 100% of the p210-positive cells express p190 with a mean p190/p210 ratio of 2610
73. The expression of p190
Bcr-Abl at a higher ratio to p210 Bcr-Abl may account for the more aggressive disease of ALL due to the disruptions of the actin cytoskeleton induced by the shorter form of BcrAbl protein.
Materials and Methods

Cell culture
Rat-1/myc cells, the gift of Robert Eisenman, were cultured in Dulbecco's modi®ed Eagle's medium (DMEM with 10% fetal calf serum 200 U/ml of penicillin, and 200 mg/ml of streptomycin. NIH3T3 cells were cultured in DMEM with 10% de®ned-supplemented bovine calf serum (HyClone), 200 U/ml of penicillin, and 200 mg/ml of streptomycin.
Plasmid construction
All of the expression plasmids used in this study except for ZIP-Bcr/64-509-Abl and Bcr/1-923-Abl have been described previously Renshaw et al., 1995) . To construct the ZIP-Bcr/64-509-Abl gene, the last 34 codons of the GCN-4 cDNA were ampli®ed by PCR. The forward and reverse primers were GAATTCGC-CATGGTGCAAAGAATGAAAC and TTAGTTGGC-GAACGCAAGCTT, respectively. The¯anking sequences of the primers (underlined) add an EcoRI site and a Kozak consensus translation initiation sequence to the 5' end and a HindIII site to the 3' end. The PCR product was cloned into the pBluescript SK + vector (Stratagene, San Diego) and sequenced using the Sequenase dideoxy sequencing kit (United States Biochemical). The pcD ZIP-Bcr/64-509-Abl gene was constructed by a three-point ligation containing the EcoRI ± HindIII PCR fragment of GCN-4, the Bcr/64-509-Abl gene isolated as a HindIII ± EcoRI fragment, and the vector pcD which had been linearized with EcoRI and dephosphorylated with calf intestinal alkaline phosphatase. The EcoRI insert of pcDZIP-Bcr/64-509-Abl was then subcloned into the BamHI site of pSLXCMV after ®lling in the ends with the Klenow fragment of DNA polymerase and adding BamHI linkers. To construct Bcr/1-923-Abl, pcD Bcr was cut at the unique MseI restrictin site at codon 923 of Bcr, end-blunted with Klenow fragment, ®tted with 8 bp XbaI linker, and cut with EcoRI. the EcoRI ± XbaI Bcr fragment containing codons 1 ± 923 was then ligated into the EcoRI and XbaI sites of pcD Bcr/1-509-Abl after removing the EcoRI-XbaI fragment containing Bcr codons 1 ± 509.
Rat-1/myc transformation assays
The assays for focus-formation and anchorage-independent growth in soft agar of Rat-1/myc cells were done as previously described .
Immunoblotting
Immunoblotting of total cell lysates with polyclonal anti-PY antibody and monoclonal anti ABL antibody 8E9 was performed as previously described (McWhirter and Wang, 1991) .
Immuno¯uorescence Double-label indirect immuno¯uorescence with anti-ABL 8E9 and¯uorescein-conjugated phalloidin was performed as previous described .
